# Bladder Cancer Adjuvant Radiotherapy Trial

> **NCT02951325** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 153 (estimated)

## Conditions studied

- Bladder Cancer
- Urothelial Carcinoma Bladder

## Interventions

- **OTHER:** Adjuvant RT

## Key facts

- **NCT ID:** NCT02951325
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-06-02
- **Primary completion:** 2024-05-08
- **Final completion:** 2030-04-13
- **Target enrollment:** 153 (ESTIMATED)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951325, "Bladder Cancer Adjuvant Radiotherapy Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02951325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*